Position in GRFS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$182,621
-$229,262 QoQ
Shares Held
25,794
-49.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 164 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Derivatives in GRFS
reported options exposure · as of Mar 31, 2024CallValue
$2,010,680
CallShares
301,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $681,590,231 across 11 Drug Manufacturers - General names. GRFS ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
1,437,685 | $181,637,122 | |
| 2 | GSK |
GSK plc
|
2,652,881 | $139,064,022 | |
| 3 | AZN |
Astrazeneca PLC
|
711,547 | $134,923,542 | |
| 4 | ABBV |
AbbVie Inc.
|
366,836 | $92,310,611 | |
| 5 | MRK |
Merck & Co., Inc.
|
380,081 | $48,840,408 | |
| 6 | SNY |
Sanofi
|
820,078 | $34,984,527 | |
| 7 | BIIB |
Biogen Inc.
|
88,149 | $19,045,472 | |
| 8 | NVS |
Novartis AG
|
106,157 | $16,636,925 |
All Filings in GRFS
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $182,621 | 25,794 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $411,883 | 51,357 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,593,746 | 277,406 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,471,092 | 147,700 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,647,088 | 182,200 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,223,019 | 172,014 | Shares | Defined | 2025-07-21 | |
| 2024-09-30 | $4,136,019 | 465,768 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,766,091 | 596,845 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $2,010,680 | 301,000 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $956,208 | 143,145 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $10,582,024 | 915,400 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $32,227,411 | 3,525,975 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $17,483,692 | 1,908,700 | Shares | Defined | 2023-08-14 | |
| 2022-09-30 | $14,682,976 | 2,383,600 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,777,888 | 233,829 | Shares | Defined | 2022-08-15 | |
| 2020-03-31 | $8,451,146 | 419,620 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||